Metabolic HealthResearch PaperPaywall

Losing thioredoxin reductase 1 in beta-cells disrupts insulin release and glucose handling in mice

In mice, deleting the antioxidant enzyme Txnrd1 in insulin-making beta-cells oxidized key metabolic proteins and impaired insulin secretion, with glucose intolerance in males.

Saturday, November 21, 2026 0 views
Published in J Biol Chem
Microscope view of pancreatic islet tissue in a lab, with a researcher's gloved hand holding a mouse glucose-testing strip

Summary

Insulin-producing beta-cells in the pancreas rely on antioxidant systems to stay healthy. This mouse and cell study asked what happens when one key antioxidant enzyme, thioredoxin reductase 1 (Txnrd1), is removed from beta-cells. Without it, the cells showed weaker calcium signaling and secreted less insulin in response to glucose. Proteins that help burn glucose in mitochondria, including GPD2 and VDAC, became more oxidized. The cells also had a lower NAD+/NADH ratio, less pyruvate inside the cell and more lactate outside, a sign that glucose metabolism was disrupted. Mice lacking Txnrd1 only in beta-cells were glucose intolerant, though this reached statistical significance only in males. The work points to a specific redox mechanism linking antioxidant capacity to insulin secretion. It is preclinical, has not been tested in people, and says nothing yet about lifespan or treatment.

Detailed Summary

Why it matters: Loss of beta-cell function is central to type 2 diabetes, a major driver of age-related decline. Beta-cells are often described as vulnerable to oxidative stress, but how their antioxidant defenses keep insulin secretion working is not fully mapped. This study examines one such defense, thioredoxin reductase 1 (Txnrd1).

What was studied: The researchers removed or depleted Txnrd1 in beta-cells, using cell models and mice with a beta-cell-specific knockout. They measured glucose-stimulated calcium flux and insulin secretion, whole-animal glucose tolerance, protein oxidation, and markers of glucose metabolism.

Key results: Txnrd1 depletion impaired glucose-stimulated calcium flux and insulin secretion. Knockout mice showed glucose intolerance, but the effect reached statistical significance only in males. At the mechanism level, proteins involved in glucose metabolism were more oxidized, including mitochondrial glycerol-3-phosphate dehydrogenase (GPD2) and the voltage-dependent anion channel (VDAC). Txnrd1-deficient beta-cells had a reduced NAD+/NADH ratio, lower intracellular pyruvate and higher extracellular lactate, indicating redox-linked disruption of glucose metabolism.

Implications: The findings suggest the thioredoxin system does more than limit damage. It helps keep the metabolic machinery that couples glucose sensing to insulin release working. Because NAD+/NADH balance is a recurring theme in aging biology, the work is relevant to thinking about redox state and beta-cell resilience.

Caveats: This is a loss-of-function study in mice and cells, so it shows the enzyme is necessary, not that boosting it would help. The abstract reports no lifespan data and no human data. The sex difference in glucose intolerance is unexplained. This summary rests on the abstract only, so effect sizes and sample sizes are unavailable.

Key Findings

  • Mechanism: Txnrd1 depletion impaired glucose-stimulated calcium flux and insulin secretion in beta-cells.
  • Function: beta-cell-specific Txnrd1 knockout mice were glucose intolerant, significant only in males.
  • Mechanism: GPD2 and VDAC, mitochondrial proteins tied to glucose metabolism, were more oxidized without Txnrd1.
  • Mechanism: Txnrd1-deficient beta-cells had a lower NAD+/NADH ratio, less pyruvate and more extracellular lactate.
  • Lifespan and human outcomes were not reported in the abstract.

Methodology

Preclinical study using Txnrd1 depletion in beta-cells and a beta-cell-specific knockout mouse model. Endpoints included glucose-stimulated calcium flux, insulin secretion, glucose tolerance, protein oxidation and metabolite measurements (NAD+/NADH, pyruvate, lactate). Details such as group sizes and statistics were not available in the abstract.

Study Limitations

This summary is based on the abstract only, so sample sizes, effect magnitudes and statistics could not be assessed. The work is a knockout in mice and cells; it shows necessity, not benefit from enhancement, and no lifespan or human data are reported. The glucose intolerance reached significance only in males, leaving the female result unresolved.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: